R1 RCM and Microsoft Expand their Collaboration to Develop Generative AI and Revenue Cycle Management Platform
Shots:
- R1 RCM and Microsoft have expanded their collaboration to speed up the development and integration of R1’s proprietary technology and Microsoft’s Azure OpenAI Service
- The company will use Microsoft's Azure OpenAI Service and other services to enhance its technology, automations, workflows, and algorithms enabling rapid development of new product features for increased productivity, improved customer & patient experiences, and quicker time-to-value
- Additionally, R1 has recently introduced large language model (LLM) application integrated with Azure AI Studio tools to analyse unstructured medical records, predicting physician E/M codes, and enhancing coding quality across patient charts. It was conceptualized and deployed in under 4mos.
Ref: Globenewswire | Image: R1 RCM
Related News:- Novo Nordisk Collaborated with Microsoft to Advance Drug Discovery and Development Using AI
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Shivani is a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.
